MedPath

Oral Sulfate Solution (SUPREP) Versus Polyethylene Glycol (PEG) Plus Ascorbic Acid

Phase 4
Completed
Conditions
Cathartic Colon
Interventions
Registration Number
NCT02761213
Lead Sponsor
Bo-In Lee
Brief Summary

The aims of the present study is to compare oral sulfate solution (OSS) with low-dose polyethylene glycol plus ascorbic acid (2-L PEG/Asc) for bowel cleansing efficacy.

Detailed Description

High-quality bowel cleansing is critical to effective colonoscopy. Studies in the past decade have demonstrated that many clinical practices continue to have rates of adequate preparation as low as 60% to 80%.

Low-volume preparations for colonoscopy are designed to improve patient tolerability, another important aspect of bowel preparation. In addition, low-volume preparations should ideally not sacrifice efficacy. There are few data comparing the efficacy of available low-volume bowel preparations.

In this study, we describe a prospective, single-blind, randomized, controlled trial comparing oral sulfate solution (OSS) (SUPREP, Braintree Laboratories, Braintree, Mass) with low-dose polyethylene glycol plus ascorbic acid (2-L PEG/Asc).

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
200
Inclusion Criteria
  • people who receive colonoscopy
  • aged : 18-80
  • people who sign the consent
Exclusion Criteria
  • those aged over 80 years
  • the disabled
  • intestinal obstruction
  • severe constipation
  • previous history of bowel resection
  • liver cirrhosis
  • heart failure or ischemic heart disease within 6 months
  • inflammatory bowel disease
  • pregnant women
  • severe renal insufficiency
  • people who refuse to sign the consent

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
2-L PEG/Asc2-L PEG/Asclow-dose polyethylene glycol plus ascorbic acid (2-L PEG/Asc)
Oral sulfate solution (OSS)Oral sulfate solution (OSS)oral sulfate solution (OSS)
Primary Outcome Measures
NameTimeMethod
Boston Bowel Preparation Scale (BPPS)during colonoscopy
Aronchick scaleduring colonoscopy

Aronchick scale is a commonly used bowel preparation scale to grade the adequacy of cleansing of colonic segments or the entire colon.

Secondary Outcome Measures
NameTimeMethod
Colonoscopic finding: whether there is erythematous mucosal change or apthous ulcersduring colonoscopy
Percentage of cecal intubationduring colonoscopy
Insertion timeduring colonoscopy
Withdrawal timeduring colonoscopy
Adenoma detection rateduring colonoscopy
Tolerability by a patient questionnaire using 5-point Likert scaleon arrival at the endoscopy unit before colonoscopy

to assess tolerability of each bowel preparation

Safety by measuring hemodynamic and biochemical dataat baseline (in the clinic be- fore booking the colonoscopy) and on arrival at the en- doscopy suite

Biochemical data will be measured only in case of necessity such as weakness, mental change or numbness.

Trial Locations

Locations (1)

Seoul St. Mary's Hospital

🇰🇷

Seoul, Korea, Republic of

Seoul St. Mary's Hospital
🇰🇷Seoul, Korea, Republic of

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.